Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities
- 1 July 1999
- journal article
- Published by Elsevier in Human Pathology
- Vol. 30 (7) , 803-808
- https://doi.org/10.1016/s0046-8177(99)90141-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Mutation of BCL-6 Gene in Normal B Cells by the Process of Somatic Hypermutation of Ig GenesScience, 1998
- The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationNature Genetics, 1997
- Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6Science, 1997
- BCL-6 EXPRESSION IN REACTIVE LYMPHOID TISSUE AND IN B-CELL NON-HODGKIN'S LYMPHOMASThe Journal of Pathology, 1996
- Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's diseaseThe Journal of Pathology, 1995
- Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequencesBlood, 1995
- Frequent association of t(3;14) or variant with other lymphoma‐specific translocationsBritish Journal of Haematology, 1995
- LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patientsBlood, 1994
- Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphomaBlood, 1994
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990